Investors attribute Jiangsu Kanion Pharmaceutical Co.,Ltd.'s...

Investors attribute Jiangsu Kanion Pharmaceutical Co.,Ltd.'s low P/E ratio to limited future growth expectations. The poor earnings outlook contributes to its low P/E, with shareholders not anticipating pleasant surprises in future earnings, making a significant share price rise unlikely.